Related Experiment Videos
Clinical manifestations and management of pediatric HIV infection
Insights
Human Immunodeficiency Virus (HIV) infection is a global epidemic, with millions affected in India. This review covers pediatric HIV manifestations and antiretroviral therapy challenges in developing nations.
Area of Science:
- Infectious Diseases
- Public Health
- Pediatrics
Background:
- Human Immunodeficiency Virus (HIV) infection presents a significant global health challenge, with millions infected worldwide and a substantial burden in India.
- The epidemic is evolving, with increasing HIV seropositivity in antenatal populations and a shift from high-risk groups to the general population.
- Pediatric HIV infection in developing countries like India is complicated by diverse clinical presentations and challenges in accessing diagnostic facilities and affordable antiretroviral therapy.
Purpose of the Study:
- To review the clinical manifestations of pediatric HIV infection relevant to developing countries.
- To discuss recent advances in antiretroviral therapy (ART) for HIV in the context of resource-limited settings.
- To highlight the challenges in diagnosis and management of pediatric HIV in India.
Main Methods:
- Review of current literature on pediatric HIV infection.
- Analysis of epidemiological data on HIV prevalence in India.
- Discussion of available antiretroviral drugs and treatment guidelines.
Main Results:
- Pediatric HIV infection exhibits varied clinical symptoms, posing diagnostic challenges in early infancy.
- Access to advanced diagnostics (HIV-PCR, CD4/CD8 counts) and sustained antiretroviral therapy is limited and costly in India.
- Current treatment emphasis in India is on preventing opportunistic infections and mother-to-child transmission using zidovudine.
Conclusions:
- Adapting international treatment guidelines for pediatric HIV is crucial for the Indian context.
- Addressing diagnostic accessibility, drug availability, and cost of antiretroviral therapy is essential for effective pediatric HIV management.
- Prevention of perinatal transmission and management of opportunistic infections remain key strategies in India.
Abstract:
HIV infection has emerged as a colossal problem with epidemic proportions. According to an estimate from UNAIDS about 36.1 million people all over the world are infected at present. In India about 3.5 million people are infected. The infection has evolved into phase II process of disease evolution, spreading from high-risk population to the general population. The antenatal HIV seropositivity has shown a steady increase from 0.1% to 2% in some tertiary care hospitals in Mumbai. Pediatric HIV infection presents with diverse clinical manifestations. In developing countries like India, diagnosis of infection during first year of life in perinatally exposed infants poses a problem due to lack of easy accessibility and increased cost of diagnostic facilities like HIV-PCR, CD4/CD8 counts and viral cultures. Moreover, lack of adequate drugs and exorbitant cost of sustaining antiretroviral therapy complicates the management issues. An assortment of antiretovirals is available in USA and other developed countries. In India drugs like zidovudine, lamivudine, stavudine, nevirapine and indinavir are available and are used in symptomatic patients. CDC has defined definite treatment guidelines for pediatric population recently. These guidelines need to be modified in our set up. At the present juncture in India the emphasis remains on the prevention and treatment of opportunistic infections like tuberculosis and pneumocystis carinii and on prevention of perinatal transmission with zidovudine. This brief review deals with various clinical manifestations as relevant in a developing country like India and recent advances in antiretroviral therapy.